22 results
424B3
BIAF
bioAffinity Technologies, Inc.
23 Sep 24
Prospectus supplement
4:00pm
stockholder approval, which could be used to institute a stockholder rights plan, or so-called “poison pill,” that would work to dilute the stock ownership
8-K
EX-10.1
BIAF
bioAffinity Technologies, Inc.
5 Aug 24
Entry into a Material Definitive Agreement
9:03am
acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under
424B5
BIAF
bioAffinity Technologies, Inc.
5 Aug 24
Prospectus supplement for primary offering
9:00am
to issue Preferred Stock without stockholder approval, which could be used to institute a stockholder rights plan, or so-called “poison pill,” that would
424B3
BIAF
bioAffinity Technologies, Inc.
16 Apr 24
Prospectus supplement
7:19pm
a stockholder rights plan, or so-called “poison pill,” that would work to dilute the stock ownership of a potential hostile acquirer, effectively preventing
POS AM
h6932991ra
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
8-K
EX-10.1
kdov4ug xwh
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
424B5
4g7jaekwwm46bxgpa
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
0wvps
7 Mar 24
Prospectus supplement for primary offering
9:57pm
424B5
w630e9u3v0a0vqq60jn
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
jfiv4d r8nwp8is63gxu
16 Nov 23
Shelf registration
5:23pm
DRS
t12 djv9z9qt974
14 Aug 23
Draft registration statement
12:00am
424B4
52sb5d
2 Sep 22
Prospectus supplement with pricing info
3:25pm